In summary, our study highlights that IL-6, VEGF, PDGF-BB, IP-10, MCP-1, and IL-9 exhibit complex and often context-dependent roles in tumours, making them both potential biomarkers and therapeutic targets. Here, CCL2 is linked to neoplasm.